S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
S&P 500   3,923.68 (-4.04%)
DOW   31,490.07 (-3.57%)
QQQ   291.14 (-4.91%)
AAPL   140.82 (-5.64%)
MSFT   254.08 (-4.77%)
FB   192.24 (-5.12%)
GOOGL   2,237.99 (-3.93%)
AMZN   2,142.25 (-7.16%)
TSLA   709.81 (-6.80%)
NVDA   169.38 (-6.82%)
BABA   87.31 (-5.09%)
NIO   15.83 (-4.81%)
AMD   96.28 (-6.04%)
CGC   5.59 (-5.09%)
MU   71.05 (-4.61%)
T   20.23 (-1.65%)
GE   75.20 (-1.57%)
F   12.78 (-5.54%)
DIS   104.30 (-3.99%)
AMC   12.76 (-1.09%)
PFE   50.40 (-1.83%)
PYPL   77.18 (-3.22%)
NFLX   177.19 (-7.02%)
NASDAQ:FMTX

Forma Therapeutics SEC Filings & 10K Form

$5.98
-0.76 (-11.28%)
(As of 05/18/2022 04:00 PM ET)
Add
Compare
Today's Range
$5.76
$6.65
50-Day Range
$5.98
$10.00
52-Week Range
$5.76
$31.39
Volume
447,112 shs
Average Volume
528,559 shs
Market Capitalization
$285.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.39

Forma Therapeutics (NASDAQ:FMTX) SEC Filings

DateFilerForm TypeView
05/10/2022
9:13 AM
FMR LLC (Filed by)
Forma Therapeutics (Subject)
Form SC 13G/A
05/06/2022
3:06 PM
Forma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2022
6:31 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2022
11:15 PM
Forma Therapeutics (Filer)
Form EFFECT
04/27/2022
3:05 PM
Forma Therapeutics (Filer)
Form DEFA14A
04/14/2022
5:10 PM
Forma Therapeutics (Issuer)
Kelly Patrick F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2021
3:06 PM
Forma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2021
6:15 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2021
6:09 PM
Forma Therapeutics (Issuer)
Vickers Selwyn M MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:06 PM
Forma Therapeutics (Issuer)
Frederick Wayne A.I. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:05 PM
Forma Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:04 PM
CLACKSON TIMOTHY P (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:04 PM
Fanucci Marsha (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:02 PM
Forma Therapeutics (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
6:01 PM
Forma Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2021
4:04 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2021
3:15 PM
Bishop John E (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:12 PM
Bishop John E (Reporting)
Forma Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/14/2021
6:12 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
6:12 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2021
6:32 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2021
3:36 PM
Forma Therapeutics (Filer)
Form DEFA14A
04/21/2021
3:33 PM
Forma Therapeutics (Filer)
Form DEF 14A
04/05/2021
3:31 PM
Forma Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
4:09 PM
Forma Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/30/2021
6:30 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2021
3:29 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2021
8:46 AM
FMR LLC (Filed by)
Forma Therapeutics (Subject)
Form SC 13G/A
03/02/2021
7:34 PM
Forma Therapeutics (Issuer)
Potts Jeannette (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:31 PM
Forma Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:29 PM
COOK DAVID N (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:28 PM
Forma Therapeutics (Issuer)
Shegog Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:23 PM
Forma Therapeutics (Issuer)
Lee Frank D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:20 PM
Forma Therapeutics (Issuer)
Kelly Patrick F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2021
2:06 PM
Cormorant Asset Management, LP (Filed by)
Forma Therapeutics (Subject)
Form SC 13G/A
02/12/2021
4:16 PM
Forma Therapeutics (Subject)
Lilly Ventures Fund I LLC (Filed by)
Form SC 13G
02/02/2021
2:16 PM
BlackRock Inc. (Filed by)
Forma Therapeutics (Subject)
Form SC 13G
02/01/2021
3:09 PM
Forma Therapeutics (Subject)
Novartis Bioventures Ltd (Filed by)
Form SC 13G
01/11/2021
4:47 PM
Forma Therapeutics (Issuer)
Vickers Selwyn M MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
4:44 PM
Forma Therapeutics (Issuer)
Vickers Selwyn M MD (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/08/2021
3:03 PM
Forma Therapeutics (Issuer)
Potts Jeannette (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
3:35 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
3:09 PM
Forma Therapeutics (Filer)
Form 424B4
12/10/2020
11:15 PM
Forma Therapeutics (Filer)
Form EFFECT
12/10/2020
7:18 PM
Forma Therapeutics (Filer)
Form S-1MEF
12/08/2020
3:46 PM
Forma Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/25/2020
5:20 PM
Forma Therapeutics (Issuer)
Hall Steven Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
6:30 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:05 PM
Forma Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
3:05 PM
Forma Therapeutics (Issuer)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
3:02 PM
Forma Therapeutics (Issuer)
WIGGANS THOMAS G (Reporting)
WIGGANS THOMAS G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/09/2020
3:02 PM
Forma Therapeutics (Issuer)
Forma Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/09/2020
3:00 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:00 PM
Forma Therapeutics (Filer)
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2020
3:06 PM
Forma Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2020
6:17 AM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
7:28 PM
Forma Therapeutics (Issuer)
Frederick Wayne A.I. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2020
7:06 PM
Forma Therapeutics (Issuer)
Frederick Wayne A.I. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/30/2020
5:49 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2020
5:41 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2020
4:48 PM
Forma Therapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2020
4:02 PM
Forma Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D
06/24/2020
8:27 PM
Forma Therapeutics (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:25 PM
Forma Therapeutics (Issuer)
Kelly Patrick F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:23 PM
Fanucci Marsha (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:22 PM
CLACKSON TIMOTHY P (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:22 PM
Forma Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:20 PM
Forma Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:19 PM
Forma Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
8:17 PM
Forma Therapeutics (Issuer)
Paoletti Paolo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2020
3:49 PM
Forma Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2020
5:08 AM
Forma Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/22/2020
6:41 PM
COOK DAVID N (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:38 PM
Forma Therapeutics (Issuer)
Potts Jeannette (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:36 PM
Forma Therapeutics (Issuer)
Lee Frank D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:34 PM
Fanucci Marsha (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:32 PM
Forma Therapeutics (Issuer)
Paoletti Paolo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:31 PM
Forma Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:28 PM
Forma Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:28 PM
Forma Therapeutics (Issuer)
WIRTH PETER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:26 PM
Forma Therapeutics (Issuer)
Kelly Patrick F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:25 PM
CLACKSON TIMOTHY P (Reporting)
Forma Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:24 PM
Forma Therapeutics (Issuer)
Shegog Todd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
6:23 PM
Forma Therapeutics (Issuer)
Hall Steven Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2020
4:09 PM
Forma Therapeutics (Filer)
Form 424B4
06/18/2020
11:15 PM
Forma Therapeutics (Filer)
Form EFFECT
06/18/2020
8:52 PM
CLACKSON TIMOTHY P (Reporting)
Forma Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:37 PM
Forma Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:36 PM
Fanucci Marsha (Reporting)
Forma Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:36 PM
Forma Therapeutics (Issuer)
Kelly Patrick F. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:34 PM
Forma Therapeutics (Issuer)
WIRTH PETER (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:29 PM
COOK DAVID N (Reporting)
Forma Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:29 PM
Forma Therapeutics (Issuer)
Hall Steven Edward (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:26 PM
Forma Therapeutics (Issuer)
Shegog Todd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:25 PM
Forma Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:24 PM
Forma Therapeutics (Issuer)
Paoletti Paolo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:22 PM
Forma Therapeutics (Issuer)
Potts Jeannette (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:19 PM
Forma Therapeutics (Issuer)
Wadlinger Mary E. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:19 PM
Forma Therapeutics (Issuer)
Wellington Biomedical Innovation Master Investors I L.P. (0001787092) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2020
8:17 PM
Forma Therapeutics (Issuer)
Lee Frank D. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.